• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的最新进展。

An update on nonalcoholic fatty liver disease.

作者信息

Provencher Daniel M

机构信息

Daniel M. Provencher is a lecturer and clinical coordinator at Midwestern University in Downers Grove, Ill. The author has disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2014 Jul;27(7):18-22. doi: 10.1097/01.JAA.0000450801.19545.93.

DOI:10.1097/01.JAA.0000450801.19545.93
PMID:24901731
Abstract

Nonalcoholic fatty liver disease (NAFLD) is the accumulation of fat (steatosis) in the liver for reasons other than excess alcohol intake. The diagnosis of NAFLD is becoming more common for a number of reasons, including increased awareness among healthcare providers, improved diagnostic tools, and a greater prevalence of the disorder. This article provides primary care providers with the current understanding of NAFLD, including evidence-based recommendations for managing patients with this common condition.

摘要

非酒精性脂肪性肝病(NAFLD)是指因过量饮酒以外的原因导致肝脏中脂肪堆积(脂肪变性)。由于多种原因,NAFLD的诊断越来越普遍,这些原因包括医疗服务提供者的认识提高、诊断工具的改进以及该疾病的患病率上升。本文为初级保健提供者提供了对NAFLD的当前认识,包括针对管理患有这种常见疾病的患者的循证建议。

相似文献

1
An update on nonalcoholic fatty liver disease.非酒精性脂肪性肝病的最新进展。
JAAPA. 2014 Jul;27(7):18-22. doi: 10.1097/01.JAA.0000450801.19545.93.
2
Nonalcoholic fatty liver disease as a multi-systemic disease.非酒精性脂肪性肝病作为一种多系统疾病。
World J Gastroenterol. 2016 Apr 28;22(16):4079-90. doi: 10.3748/wjg.v22.i16.4079.
3
[Non-alcoholic fatty liver disease (NAFLD)].非酒精性脂肪性肝病(NAFLD)
Dtsch Med Wochenschr. 2015 Jul;140(14):1051-5. doi: 10.1055/s-0041-102787. Epub 2015 Jul 16.
4
Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.肥胖成年人的非酒精性脂肪性肝病:临床特点与当前管理策略
Clin Obes. 2014 Oct;4(5):243-53. doi: 10.1111/cob.12068. Epub 2014 Jul 28.
5
Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications.了解脂肪肝的形成与随后的心血管代谢并发症之间的关联。
Expert Rev Gastroenterol Hepatol. 2015;9(10):1243-5. doi: 10.1586/17474124.2015.1074860. Epub 2015 Jul 29.
6
Nonalcoholic fatty liver disease and non-liver comorbidities.非酒精性脂肪性肝病与非肝脏合并症。
Clin Mol Hepatol. 2023 Feb;29(Suppl):s86-s102. doi: 10.3350/cmh.2022.0442. Epub 2023 Jan 5.
7
[Non-alcoholic fatty liver: position document of the Catalan Society of Gastroenterology].[非酒精性脂肪性肝病:加泰罗尼亚胃肠病学会立场文件]
Gastroenterol Hepatol. 2014 Jun-Jul;37(6):372-83. doi: 10.1016/j.gastrohep.2014.03.005. Epub 2014 Apr 18.
8
Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.肥胖儿童的非酒精性脂肪性肝病与代谢综合征标准之间的关系。
Obes Res Clin Pract. 2014 Jul-Aug;8(4):e356-63. doi: 10.1016/j.orcp.2013.08.003. Epub 2013 Sep 7.
9
Nonalcoholic fatty liver disease: Evolving paradigms.非酒精性脂肪性肝病:不断变化的范式。
World J Gastroenterol. 2017 Sep 28;23(36):6571-6592. doi: 10.3748/wjg.v23.i36.6571.
10
Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.非酒精性脂肪性肝病患者心血管风险的降低:依泽替米贝的潜在作用
Dig Dis Sci. 2016 Dec;61(12):3425-3435. doi: 10.1007/s10620-016-4330-z. Epub 2016 Oct 6.

引用本文的文献

1
The impact of aerobic and anaerobic exercise interventions on the management and outcomes of non-alcoholic fatty liver disease.有氧运动和无氧运动干预对非酒精性脂肪肝的管理和结局的影响。
Physiol Res. 2024 Nov 12;73(5):671-686. doi: 10.33549/physiolres.935244.
2
Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2.TMED2杂合突变小鼠中的非酒精性脂肪性肝病
PLoS One. 2017 Aug 10;12(8):e0182995. doi: 10.1371/journal.pone.0182995. eCollection 2017.